RCKT ROCKET PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Amendment to Sales Agreement Rocket Pharmaceuticals, Inc. has entered into an amendment to a sales agreement with Cowen and Company, reducing the aggregate offering price under the ATM Offering to $180,000,000, with $114,100,000 of remaining availability.Get access to all SEC 8-K filings of the ROCKET PHARMACEUTICALS INC